Key result
Higher urinary epidermal growth factor levels measured years before heart failure hospitalization were associated with a lower risk of acute kidney injury (adjusted OR 0.49; 95% CI 0.27-0.91).
Why the study?
Predictors of acute kidney injury during acute heart failure hospitalizations remain poorly defined, particularly the role of urinary tubular health biomarkers measured years before hospitalization.
Do urinary biomarkers of tubular health measured years prior predict acute kidney injury in adults hospitalized for acute heart failure?
Case-Control (n=819)
Do urinary biomarkers of tubular health measured years prior predict acute kidney injury in adults hospitalized for acute heart failure?
Odds Ratio: 0.49 (95% CI 0.27–0.91)
Higher urinary epidermal growth factor (EGF) measured years prior to heart failure hospitalization is associated with a lower risk of developing acute kidney injury during admission, suggesting tubular health provides resilience against HF-related kidney injury.
Suggests tubular health confers resilience against heart failure-related AKI; leaves open clinical adoption of EGF as a predictive biomarker.
Rationale & Objective Acute kidney injury (AKI) frequently complicates acute heart failure (HF), yet predictors of HF-associated AKI remain poorly defined. We examined whether urinary biomarkers of tubular health, measured years before HF hospitalization predict subsequent AKI risk. Study Design Case-control study Setting & Participants Adults ≥45 years in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study hospitalized for acute heart failure (HF). We compared 400 acute kidney injury (AKI) cases with 419 frequency-matched non-AKI controls. Exposures Biomarkers of tubular function (alpha-1 microglobulin [A1M], uromodulin [UMOD], epidermal growth factor [EGF]) and injury (kidney injury molecule-1 [KIM-1]). Outcomes AKI, defined as a serum creatinine rise ≥0.3 mg/dL during HF admission. Analytical Approach Logistic regression adjusted for demographics, comorbidities, urine creatinine, time to HF, eGFR and albuminuria. Results Median time was 5.6 years from baseline to HF. AKI cases exhibited higher A1M and lower UMOD and EGF than non-AKI controls. Higher EGF was strongly associated with lower AKI risk (OR for 4th vs. 1st quartile: 0.27, 95% CI 0.16–0.46), persisting after adjustment for eGFR and albuminuria (OR 0.49, 95% CI 0.27–0.91). Continuous EGF analysis showed a similar trend but was not significant in fully adjusted models (OR per 2-fold increase: 0.89, 95% CI 0.77–1.04). No other biomarkers independently predicted AKI. Limitations Extended time from baseline to HF hospitalization. Conclusions Higher urinary EGF, measured years before HF, is associated with lower risk of AKI during HF hospitalization. Tubular health may be associated with resilience against HF-related kidney injury.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a case-control in Acute heart failure (n=819). Higher urinary epidermal growth factor (EGF) (4th quartile) vs. Lower urinary EGF (1st quartile) was evaluated on Acute kidney injury (AKI), defined as a serum creatinine rise ≥0.3 mg/dL during HF admission (OR 0.49, 95% CI 0.27-0.91). Higher urinary epidermal growth factor levels measured years before heart failure hospitalization were associated with a lower risk of acute kidney injury (adjusted OR 0.49; 95% CI 0.27-0.91).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: